Skip to main content

Bo Lu, PhD

Bo Lu, PhD

Professor and Chair of Radiation Oncology,  School of Medicine

NextGen Focus Area: Cancer and Immunology

Bo Lu conducts National Cancer Institute-sponsored research that aims to understand how Th-17/B-cell-mediated autoimmune mechanisms contribute to the efficacy and toxicity of combined cancer treatments such as radiotherapy and immunotherapy. He is investigating immunogenic signaling pathways triggered by ionizing irradiation. The ultimate goal is to identify drug targets and biomarkers that will aid the development of blood tests and novel drugs to improve the efficacy and safety of cancer treatments. 

Precision Health Impact:

  • Personalized cancer treatments based on an individual’s tumor and host immune system to maximize efficacy and minimize side effects.


     Google Scholar



Department website: